NO Whytee - I'm actually embarrased for you.
Heading refers to a pathway
Si's comments refer to an outcome after pathway completion which may be accelerated approval.
How about you provide negatives on the actual FDA comments as stated in the announcement
" the presented results may support a reasonable likelihood of clinical benefit......in LVAD patients, consistent with the criteria for accelerated approval"
When you are going to correct someone and give them a dressing down please be accurate.
Reg
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure, page-446
-
- There are more pages in this discussion • 104 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
0.030(3.06%) |
Mkt cap ! $1.136B | |||
| Open | High | Low | Value | Volume |
| $1.01 | $1.04 | 99.0¢ | $3.595M | 3.548M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 79053 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.01 | 70750 | 14 |
View Market Depth
| Last trade - 14.20pm 16/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |